# CAPA Procedure Working Template > **STATUS: DRAFT EXAMPLE — NOT APPROVED — NOT EVIDENCE OF CONFORMITY** > > Adapt this structure to approved processes, applicable requirements, product risk, > and authorized roles. A completed template or passing script cannot establish > compliance, close a CAPA, or replace RA/QA, management, legal, regulatory, auditor, > or certification-body judgment. ## Controlled-document metadata | Field | Entry | |---|---| | Document ID/revision | `` / `` | | Owner | `` | | Status | `draft` / `in-review` / `approved` | | Effective date | `` | | Evidence repository | `` | | Supersedes/change record | `` | | Approval role | Named approver | Status | Date | Approval evidence | |---|---|---|---|---| | Process owner | `` | `pending` | `` | `` | | RA/QA | `` | `pending` | `` | `` | | Authorized management | `` | `pending` | `` | `` | ## 1. Purpose and scope - Controlled purpose: `` - Products, sites, processes, and records covered: `` - Interfaces: complaints, audit, suppliers, nonconformity, risk, vigilance, design/production change, validation, training, and management review. - Exclusions or interfaces outside this procedure: `` ## 2. Roles and authority | Role | Responsibility and decision authority | Escalation | Competence evidence | Approval | |---|---|---|---|---| | CAPA system owner | `` | `` | `` | `` | | CAPA owner | `` | `` | `` | `` | | Independent effectiveness reviewer | `` | `` | `` | `` | | RA/QA reviewer | `` | `` | `` | `` | | Closure approver | `` | `` | `` | `` | ## 3. CAPA intake and decision Define controlled inputs and the approved criteria for opening, escalating, linking, combining, or declining a CAPA. Do not use an arbitrary priority label as a substitute for product/process risk and reportability review. | Input | Owner | Decision method | Evidence | Status | Approval | |---|---|---|---|---|---| | Complaint/feedback | `` | `` | `` | `draft` | `` | | Audit/nonconformity | `` | `` | `` | `draft` | `` | | Supplier issue | `` | `` | `` | `draft` | `` | | Trend/risk/postmarket signal | `` | `` | `` | `draft` | `` | Each decision record must include: - unique CAPA ID and source-event links; - factual problem statement and known scope; - correction/containment and evidence; - product, patient/user, process, and regulatory/reportability impact review; - decision owner, status, rationale, evidence, and approval. ## 4. Investigation and systemic extent The record must define the method before drawing a conclusion and preserve the evidence reviewed. | Field | Required entry | |---|---| | Investigation owner/status | `` / `draft` | | Scope and plan | `` | | Data and evidence IDs | `` | | Analysis method and rationale | `` | | Root cause or justified conclusion | `` | | Similar/systemic issue review | `` | | Risk-file/design/supplier/process impacts | `` | | Reviewer and approval evidence | `` | Do not force a preferred root-cause method. Select and approve a method appropriate to the evidence, complexity, and risk. ## 5. Action planning and change control | Action ID | Description | Owner | Due date | Change/validation/training links | Implementation evidence | Status | Approval | |---|---|---|---|---|---|---|---| | `` | `` | `` | `` | `` | `` | `planned` | `` | Actions must address the supported cause or risk, include objective acceptance criteria, and route affected documents, software, validation, suppliers, products, training, risk files, and postmarket controls through approved change control. ## 6. Effectiveness plan and review Define the effectiveness plan before closure. | Field | Required entry | |---|---| | Effectiveness owner | `` | | Independent reviewer | `` | | Objective acceptance criteria | `` | | Baseline/comparator | `` | | Data source and evidence IDs | `` | | Sample or observation window | `` | | Review date | `` | | Result | `pending` / `effective` / `ineffective` | | Conclusion and evidence | `` | | Approval | `` | **Fail-closed gate:** `pending`, insufficient data, or `ineffective` cannot support closure. Re-open the investigation/action cycle or document authorized escalation. ## 7. Closure, cancellation, and extension Closure requires: - all actions implemented with evidence; - approved effectiveness result of `effective`; - linked risk, design, production, supplier, postmarket, document, validation, and training changes completed or explicitly dispositioned; - complete source/version references; - closure summary, date, owner, status, evidence, and authorized approval. Cancellation or due-date changes require a documented rationale, risk/reportability impact review, owner, status, evidence, and approval. Neither changes the need for immediate safety or regulatory action when applicable. ## 8. Records, metrics, and management visibility | Record/measure | Owner | Retention basis | Location | Review method | Evidence | Approval | |---|---|---|---|---|---|---| | CAPA record set | `` | `` | `` | `` | `` | `` | | Aging/overdue status | `` | `` | `` | `` | `` | `` | | Recurrence/effectiveness trend | `` | `` | `` | `` | `` | `` | | Management-review input | `` | `` | `` | `` | `` | `` | ## Release checklist - [ ] Placeholders are resolved. - [ ] Interfaces to risk, complaints/vigilance, suppliers, design, production, validation, software, training, and change control are explicit. - [ ] No fixed timeline is used without an approved risk/process basis. - [ ] Effectiveness criteria are objective and approved before closure. - [ ] Records carry owner, status, evidence, source/version, and approval fields. - [ ] Authorized human approvers released the procedure. - [ ] The procedure makes no compliance or certification claim.